Experienced in Omphalocele

Dr. Karim S. Elsahwi

Gynecologic Oncology | Oncology | Obstetrics and Gynecology
HMH - Obstetrics And Gynecology - Neptune
19 Davis Avenue, Floor 7, 
Neptune, NJ 
Experienced in Omphalocele
HMH - Obstetrics And Gynecology - Neptune
19 Davis Avenue, Floor 7, 
Neptune, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Karim Elsahwi is a Gynecologic Oncologist and an Oncologist in Neptune, New Jersey. Dr. Elsahwi is rated as an Experienced provider by MediFind in the treatment of Omphalocele. His top areas of expertise are Endometrial Cancer, Malignant Mixed Mullerian Tumor, Ovarian Cancer, Hysterectomy, and Oophorectomy.

His clinical research consists of co-authoring 17 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Omphalocele.

Graduate Institution
University Of Alexandria University Hospitals
Residency
Jersey Shore University Medical Center
Specialties
Gynecologic Oncology
Oncology
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in NJ
Board Certifications
American Board Of Obstetrics And Gynecology
American Board Of Obstetrics And Gynecology
American Board Of Obstetrics And Gynecology
Fellowships
Yale University School of Medicine
Lahey Clinic Medical Center
Hospital Affiliations
Ocean Medical Center
Riverview Medical Center
Southern Ocean Medical Center
Jfk University Medical Center
Jersey Shore University Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

HMH - Obstetrics and Gynecology - Neptune
19 Davis Avenue, Floor 7, Neptune, NJ 7753.
Other Locations
1 Hospital Plaza, Suite 206, Old Bridge, NJ 8857.
HMH - Obstetrics and Gynecology - Forked River
730 Lacey Road, Suite 206, Forked River, NJ 8731.
1610 Route 88, Suite 203, Brick, NJ 8724.

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
Enrollment Status: Active_not_recruiting
Publish Date: December 01, 2025
Intervention Type: Procedure, Drug, Other
Study Drugs: Cediranib, Cediranib Maleate, Olaparib, Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride, Topotecan, Topotecan Hydrochloride
Study Phase: Phase 2/Phase 3
A Phase III Randomized Trial of Radiation +/- Pembrolizumab (MK-3475) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer
A Phase III Randomized Trial of Radiation +/- Pembrolizumab (MK-3475) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 12, 2025
Intervention Type: Other, Procedure, Radiation, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 13, 2025
Intervention Type: Drug
Study Drugs: Niraparib, Dostarlimab
Study Phase: Phase 3
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
Enrollment Status: Active_not_recruiting
Publish Date: December 10, 2024
Intervention Type: Other, Drug, Biological
Study Drugs: Bevacizumab, Carboplatin, Docetaxel, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 3
A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
Enrollment Status: Unknown
Publish Date: March 29, 2023
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
Enrollment Status: Completed
Publish Date: November 07, 2022
Intervention Type: Other, Drug, Radiation
Study Drugs: Carboplatin, Cisplatin, Paclitaxel
Study Phase: Phase 3
Can Diet and Physical Activity Modulate Ovarian, Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?
Can Diet and Physical Activity Modulate Ovarian, Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?
Enrollment Status: Unknown
Publish Date: February 19, 2018
Intervention Type: Other, Behavioral
Study Phase: Phase 3
View 6 Less Clinical Trials

17 Total Publications

Bilateral malignant struma ovarii with concurrent thyroid carcinoma.
Bilateral malignant struma ovarii with concurrent thyroid carcinoma.
Journal: BMJ case reports
Published: April 08, 2025
Similar Doctors
Distinguished in Omphalocele
Dr. Lynn L. Simpson
Neonatology | Obstetrics and Gynecology
Distinguished in Omphalocele
Dr. Lynn L. Simpson
Neonatology | Obstetrics and Gynecology

Trustees Of Columbia University In The City Of New York

3959 Broadway, 
New York, NY 
 (44.0 miles away)
212-305-5398
Languages Spoken:
English
See accepted insurances

Lynn Simpson is a Neonatologist and an Obstetrics and Gynecologist in New York, New York. Dr. Simpson is rated as an Advanced provider by MediFind in the treatment of Omphalocele. Her top areas of expertise are Omphalocele, Umbilical Hernia, Twin-To-Twin Transfusion Syndrome, Myelomeningocele, and Endoscopy.

Advanced in Omphalocele
Dr. Ronald J. Wapner
Medical Genetics | Neonatology | Obstetrics and Gynecology
Advanced in Omphalocele
Dr. Ronald J. Wapner
Medical Genetics | Neonatology | Obstetrics and Gynecology
161 Fort Washington Ave, 
New York, NY 
 (44.0 miles away)
212-305-7334
Languages Spoken:
English
See accepted insurances

Ronald Wapner is a Medical Genetics specialist and a Neonatologist in New York, New York. Dr. Wapner is rated as a Distinguished provider by MediFind in the treatment of Omphalocele. His top areas of expertise are Preeclampsia, High Blood Pressure in Infants, Gestational Diabetes, Trisomy 13, and Hysterectomy.

Jason K. Baxter
Experienced in Omphalocele
Dr. Jason K. Baxter
Obstetrics and Gynecology
Experienced in Omphalocele
Dr. Jason K. Baxter
Obstetrics and Gynecology
1235 Old York Road, Suite G18, 
Abington, PA 
 (57.3 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jason Baxter is an Obstetrics and Gynecologist in Abington, Pennsylvania. Dr. Baxter is rated as an Advanced provider by MediFind in the treatment of Omphalocele. His top areas of expertise are Cystic Adenomatoid Malformation of Lung, Pelvic Inflammatory Disease, Endometritis, and Premature Infant. Dr. Baxter is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Elsahwi's expertise for a condition
ConditionClose
    View All 11 Distinguished Conditions
    View All 10 Advanced Conditions
    View All 18 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile